US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Methylcobalamin 10 mg/mL Injection

Reason Lack of Assurance of Sterility.

First Pharma Associates LLC dba Riverpoint Pharmacy D-1478-2019
Class II · Moderate risk Terminated

Methylcobalamin 1 mg/mL Injection

Reason Lack of Assurance of Sterility.

First Pharma Associates LLC dba Riverpoint Pharmacy D-1477-2019
Class II · Moderate risk Terminated

Hydroxocobalamin 10 mg/mL Injection

Reason Lack of Assurance of Sterility.

First Pharma Associates LLC dba Riverpoint Pharmacy D-1476-2019
Class III · Low risk Terminated

Smart Sense Regular Strength Aspirin Tablets

Reason Labeling; Incorrect or Missing Lot Number and/or Exp Date; Product has an incorrect expiration date of 9/2022 applied to the labeling, where the actual expiration date is 10/2021.

AAA Pharmaceutical, Inc. D-1585-2019
Class II · Moderate risk Terminated

Diphenhydramine HCL Liquid

Reason Microbial Contamination of Non-sterile Products: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

H J Harkins Company Inc dba Pharma Pac NDC 52959-0123-03 D-1430-2019
Class II · Moderate risk Terminated

Acetaminophen Children's Liquid

Reason Microbial Contamination of Non-sterile Products: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

H J Harkins Company Inc dba Pharma Pac NDC 52959-0309-04 D-1429-2019
Class II · Moderate risk Terminated

Workvie Instant Pain Relieving Roll On

Reason CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Pharma-Natural Inc. NDC 72393-201-25 D-1507-2019
Class II · Moderate risk Terminated

Neogen-D

Reason CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Pharma-Natural Inc. NDC 52083-699-16 D-1506-2019
Class II · Moderate risk Terminated

Sorbugen Nr

Reason CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Pharma-Natural Inc. NDC 52083-660-16 D-1505-2019
Class II · Moderate risk Terminated

Tusslin

Reason CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Pharma-Natural Inc. NDC 52083-622-16 D-1504-2019
Class II · Moderate risk Terminated

Dayma SUPER FORTE XL10

Reason CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Pharma-Natural Inc. NDC 63788-118-04 D-1503-2019
Class II · Moderate risk Terminated

Lid O Creme

Reason CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Pharma-Natural Inc. NDC 63788-111-25 D-1502-2019
Class II · Moderate risk Terminated

Lido E.R.

Reason CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Pharma-Natural Inc. NDC 63788-115-04 D-1501-2019
Class II · Moderate risk Terminated

Dermanak original crema blanqueador

Reason CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Pharma-Natural Inc. NDC 63788-108-02 D-1500-2019
Class II · Moderate risk Terminated

LidoAID

Reason CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Pharma-Natural Inc. NDC 63788-114-04 D-1499-2019
Class II · Moderate risk Terminated

Double Tussin Dm

Reason CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Pharma-Natural Inc. NDC 63708-121-04 D-1498-2019